These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 7510716)
1. The apoptosis-1/Fas protein in human systemic lupus erythematosus. Mysler E; Bini P; Drappa J; Ramos P; Friedman SM; Krammer PH; Elkon KB J Clin Invest; 1994 Mar; 93(3):1029-34. PubMed ID: 7510716 [TBL] [Abstract][Full Text] [Related]
2. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus. Wang H; Xu J; Ji X; Yang X; Sun K; Liu X; Shen Y Cell Immunol; 2005 Jun; 235(2):117-21. PubMed ID: 16226734 [TBL] [Abstract][Full Text] [Related]
3. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus. Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908 [TBL] [Abstract][Full Text] [Related]
4. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Lorenz HM; Grünke M; Hieronymus T; Herrmann M; Kühnel A; Manger B; Kalden JR Arthritis Rheum; 1997 Feb; 40(2):306-17. PubMed ID: 9041943 [TBL] [Abstract][Full Text] [Related]
5. Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha. Habib HM; Taher TE; Isenberg DA; Mageed RA Scand J Rheumatol; 2009; 38(2):112-20. PubMed ID: 19110660 [TBL] [Abstract][Full Text] [Related]
6. Increased Fas and Bcl-2 expression on peripheral mononuclear cells from patients with active juvenile-onset systemic lupus erythematosus. Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C J Rheumatol; 2007 Jul; 34(7):1580-4. PubMed ID: 17516614 [TBL] [Abstract][Full Text] [Related]
7. Apoptosis in SLE--too little or too much? Elkon KB Clin Exp Rheumatol; 1994; 12(5):553-9. PubMed ID: 7531124 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of Fas/Fas ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus. Suzuki N; Ichino M; Mihara S; Kaneko S; Sakane T Arthritis Rheum; 1998 Feb; 41(2):344-53. PubMed ID: 9485093 [TBL] [Abstract][Full Text] [Related]
9. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus? Bijl M; van Lopik T; Limburg PC; Spronk PE; Jaegers SM; Aarden LA; Smeenk RJ; Kallenberg GG J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929 [TBL] [Abstract][Full Text] [Related]
10. Apoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus erythematosus. Seki M; Ushiyama C; Seta N; Abe K; Fukazawa T; Asakawa J; Takasaki Y; Hashimoto H Arthritis Rheum; 1998 May; 41(5):823-30. PubMed ID: 9588733 [TBL] [Abstract][Full Text] [Related]
11. Increased expression of functional Fas-ligand in activated T cells from patients with systemic lupus erythematosus. Kovacs B; Liossis SN; Dennis GJ; Tsokos GC Autoimmunity; 1997; 25(4):213-21. PubMed ID: 9344329 [TBL] [Abstract][Full Text] [Related]
12. Defective expression of the apoptosis-inducing CD95 (Fas/APO-1) molecule on T and B cells in IDDM. Giordano C; De Maria R; Stassi G; Todaro M; Richiusa P; Giordano M; Testi R; Galluzzo A Diabetologia; 1995 Dec; 38(12):1449-54. PubMed ID: 8786019 [TBL] [Abstract][Full Text] [Related]
13. Expression and function of Fas antigen and bcl-2 in human systemic lupus erythematosus lymphocytes. Ohsako S; Hara M; Harigai M; Fukasawa C; Kashiwazaki S Clin Immunol Immunopathol; 1994 Oct; 73(1):109-14. PubMed ID: 7523011 [TBL] [Abstract][Full Text] [Related]
15. Increased Fas and Bcl-2 expression on peripheral blood T and B lymphocytes from juvenile-onset systemic lupus erythematosus, but not from juvenile rheumatoid arthritis and juvenile dermatomyositis. Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C Clin Dev Immunol; 2006; 13(2-4):283-7. PubMed ID: 17162369 [TBL] [Abstract][Full Text] [Related]